Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases

Introduction: Fournier’s gangrene is a serious necrotizing infection that can be fatal if not promptly attended. Treatment for this condition consists of a combination of surgical debridement, antibiotherapy and supportive care. Hyperbaric oxygen therapy is used as an adjuvant for the optimization...

Full description

Bibliographic Details
Main Authors: Isabel Rosa, Francisco Guerreiro
Format: Article
Language:English
Published: Ordem dos Médicos 2015-09-01
Series:Acta Médica Portuguesa
Subjects:
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300
_version_ 1811242386817286144
author Isabel Rosa
Francisco Guerreiro
author_facet Isabel Rosa
Francisco Guerreiro
author_sort Isabel Rosa
collection DOAJ
description Introduction: Fournier’s gangrene is a serious necrotizing infection that can be fatal if not promptly attended. Treatment for this condition consists of a combination of surgical debridement, antibiotherapy and supportive care. Hyperbaric oxygen therapy is used as an adjuvant for the optimization of infected tissue oxygenation and for its bactericidal and bacteriostatic effects. Material and Methods: The data presented in this study encompass a period of 25 years of clinical records of patients with Fournier’s gangrene that had been treated at our center with hyperbaric oxygen therapy. Results: A total of 34 patients were treated. The vast majority of patients were males (94.1%) with a mean age of 53.7 years. Urinary tract was the most frequent source of infection and diabetes was most common comorbidity seen in patients. Mortality rate was 20.8%. Discussion: The most common observed comorbidity was diabetes, suggesting diabetes as one predisposing factor. The majority of deceased patients had diabetes, although no significant correlation between diabetes and death was found. The area of residence of patients may affect patients’ referral to these facilities. Conclusions: Although Fournier’s gangrene is a rare condition, it is nevertheless a fatal illness, namely in patients with comorbidities like diabetes. Hyperbaric oxygen therapy is recommended as an adjuvant to conventional therapy and should be considered whenever available. To further assess the role of hyperbaric oxygen therapy, in the treatment of this condition, additional studies should be carried out.
first_indexed 2024-04-12T13:50:28Z
format Article
id doaj.art-8bc56049cb5f49cbbb2f4f80183b48b1
institution Directory Open Access Journal
issn 0870-399X
1646-0758
language English
last_indexed 2024-04-12T13:50:28Z
publishDate 2015-09-01
publisher Ordem dos Médicos
record_format Article
series Acta Médica Portuguesa
spelling doaj.art-8bc56049cb5f49cbbb2f4f80183b48b12022-12-22T03:30:33ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07582015-09-0128510.20344/amp.6300Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 CasesIsabel Rosa0Francisco Guerreiro1Centro de Medicina Subaquática e Hiperbárica da Marinha. Lisboa. Portugal.Centro de Medicina Subaquática e Hiperbárica da Marinha. Lisboa. Portugal. Introduction: Fournier’s gangrene is a serious necrotizing infection that can be fatal if not promptly attended. Treatment for this condition consists of a combination of surgical debridement, antibiotherapy and supportive care. Hyperbaric oxygen therapy is used as an adjuvant for the optimization of infected tissue oxygenation and for its bactericidal and bacteriostatic effects. Material and Methods: The data presented in this study encompass a period of 25 years of clinical records of patients with Fournier’s gangrene that had been treated at our center with hyperbaric oxygen therapy. Results: A total of 34 patients were treated. The vast majority of patients were males (94.1%) with a mean age of 53.7 years. Urinary tract was the most frequent source of infection and diabetes was most common comorbidity seen in patients. Mortality rate was 20.8%. Discussion: The most common observed comorbidity was diabetes, suggesting diabetes as one predisposing factor. The majority of deceased patients had diabetes, although no significant correlation between diabetes and death was found. The area of residence of patients may affect patients’ referral to these facilities. Conclusions: Although Fournier’s gangrene is a rare condition, it is nevertheless a fatal illness, namely in patients with comorbidities like diabetes. Hyperbaric oxygen therapy is recommended as an adjuvant to conventional therapy and should be considered whenever available. To further assess the role of hyperbaric oxygen therapy, in the treatment of this condition, additional studies should be carried out. https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300Fournier GangreneHyperbaric Oxygenation.
spellingShingle Isabel Rosa
Francisco Guerreiro
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases
Acta Médica Portuguesa
Fournier Gangrene
Hyperbaric Oxygenation.
title Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases
title_full Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases
title_fullStr Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases
title_full_unstemmed Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases
title_short Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases
title_sort hyperbaric oxygen therapy for the treatment of fournier s gangrene a review of 34 cases
topic Fournier Gangrene
Hyperbaric Oxygenation.
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300
work_keys_str_mv AT isabelrosa hyperbaricoxygentherapyforthetreatmentoffourniersgangreneareviewof34cases
AT franciscoguerreiro hyperbaricoxygentherapyforthetreatmentoffourniersgangreneareviewof34cases